Guo-Pan Yu (Guopan Yu)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Acute Myeloid Leukemia

Induced Apoptosis

Endoplasmic Reticulum Stress

Top Venues

Nature cell biology

Leukemia & lymphoma

Blood cancer journal

This page only lists publications with an associated author ORCID identifier.

Publications

Rong-Yi Shi, Neng Zhou, Li Xuan, Zhong-Hui Jiang, Jing Xia, Jian-Min Zhu, Kai-Ming Chen, Guo-Li Zhou, Guo-Pan Yu, Jun Zhang, Chuanxin Huang, Ai-Bin Liang, Kai-Wei Liang, Hao Zhang, Jian-Feng Chen, Dachuan Zhang, Yi Zhong, Qi-Fa Liu, Guo-Qiang Chen, Cai-Wen Duan
Trafficking circuit of CD8 + T cells between the intestine and bone marrow governs antitumour immunity. Nature cell biology (2024)
Rong-Yi Shi, Neng Zhou, Li Xuan, Zhong-Hui Jiang, Jing Xia, Jian-Min Zhu, Kai-Ming Chen, Guo-Li Zhou, Guo-Pan Yu, Jun Zhang, Chuanxin Huang, Ai-Bin Liang, Kai-Wei Liang, Hao Zhang, Jian-Feng Chen, Dachuan Zhang, Yi Zhong, Qi-Fa Liu, Guo-Qiang Chen, Cai-Wen Duan
Trafficking circuit of CD8 + T cells between the intestine and bone marrow governs antitumour immunity. Nature cell biology 26 (8) (2024)
Zhao Yin, Ya Gao, Xiaoyin Bu, Junhui Wang, Zurong Yao, Qifa Liu, Yu Zhang, Guo-Pan Yu, Baohong Ping
Homoharringtonine sensitized resistant acute myeloid leukemia cells to venetoclax-induced apoptosis. Leukemia & lymphoma (2024)
Dan Xu, Ying Yang, Zhao Yin, Sanfang Tu, Danian Nie, Yiqing Li, Zhenqian Huang, Qixin Sun, Changfen Huang, Xiaqi Nie, Zurong Yao, Pengcheng Shi, Yu Zhang, Xuejie Jiang, Qi-Fa Liu, Guo-Pan Yu
Risk-directed therapy based on genetics and MRD improves the outcomes of AML1-ETO-positive AML patients, a multi-center prospective cohort study. Blood cancer journal 13 (1) (2023)
Dan Xu, Yishan Chen, Ying Yang, Zhao Yin, Changfen Huang, Qiang Wang, Ling Jiang, Xuejie Jiang, Changxin Yin, Qifa Liu, Guo-Pan Yu
Autophagy activation mediates resistance to FLT3 inhibitors in acute myeloid leukemia with FLT3-ITD mutation. Journal of translational medicine 20 (1) (2022)
Xiaoxia Chen, Junwei Huang, Na Xu, Zhiping Fan, Danian Nie, Fen Huang, Qixin Sun, Xinyou Zhang, Xinquan Liang, Pengcheng Shi, Zhixiang Wang, Hui Liu, Jun Xu, Min Dai, Guo-Pan Yu, Yu Zhang, Jing Sun, Qi-Fa Liu, Li Xuan
A phase 2 study of sorafenib combined with conventional therapies in refractory central nervous system leukemia. Cancer 128 (11) (2022)